Detalhe da pesquisa
1.
First-line pembrolizumab plus chemotherapy for advanced/metastatic esophageal cancer: 1-year extended follow-up in the Japanese subgroup of the phase 3 KEYNOTE-590 study.
Esophagus
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38607538
2.
Second-line pembrolizumab versus chemotherapy in Japanese patients with advanced esophageal cancer: subgroup analysis from KEYNOTE-181.
Esophagus
; 19(1): 137-145, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34591237
3.
Immunoenzymometric assay for a small molecule,11-deoxycortisol, with attomole-range sensitivity employing an scFv-enzyme fusion protein and anti-idiotype antibodies.
Anal Chem
; 78(7): 2244-53, 2006 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16579604